- Home
- OCC vs IGC Comparison
OCC vs IGC Comparison
Compare OCC & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- IGC
- Stock Information
- Founded
- OCC 1983
- IGC 2005
- Country
- OCC United States
- IGC United States
- Employees
- OCC N/A
- IGC N/A
- Industry
- OCC Telecommunications Equipment
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- IGC Health Care
- Exchange
- OCC Nasdaq
- IGC Nasdaq
- Market Cap
- OCC 23.4M
- IGC 20.2M
- IPO Year
- OCC 1996
- IGC N/A
- Fundamental
- Price
- OCC $3.00
- IGC $0.30
- Analyst Decision
- OCC
- IGC Strong Buy
- Analyst Count
- OCC 0
- IGC 2
- Target Price
- OCC N/A
- IGC $3.88
- AVG Volume (30 Days)
- OCC 11.4K
- IGC 190.2K
- Earning Date
- OCC 06-09-2025
- IGC 06-23-2025
- Dividend Yield
- OCC N/A
- IGC N/A
- EPS Growth
- OCC N/A
- IGC N/A
- EPS
- OCC N/A
- IGC N/A
- Revenue
- OCC $67,561,951.00
- IGC $1,236,000.00
- Revenue This Year
- OCC N/A
- IGC N/A
- Revenue Next Year
- OCC N/A
- IGC $16.45
- P/E Ratio
- OCC N/A
- IGC N/A
- Revenue Growth
- OCC N/A
- IGC 1.65
- 52 Week Low
- OCC $2.02
- IGC $0.25
- 52 Week High
- OCC $7.00
- IGC $0.62
- Technical
- Relative Strength Index (RSI)
- OCC 48.32
- IGC 51.47
- Support Level
- OCC $3.06
- IGC $0.28
- Resistance Level
- OCC $3.28
- IGC $0.32
- Average True Range (ATR)
- OCC 0.19
- IGC 0.01
- MACD
- OCC 0.05
- IGC 0.00
- Stochastic Oscillator
- OCC 45.16
- IGC 55.80
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.